Praveena Yetur, MD Pathology - Cytopathology Medicare: Not Enrolled in Medicare Practice Location: 250 S Grand Ave, Glendora, CA 91741 Phone: 626-857-3201 |
Yan Wang, MD Pathology - Cytopathology Medicare: Accepting Medicare Assignments Practice Location: 250 S Grand Ave, Glendora, CA 91741 Phone: 626-857-3120 |
Tony M Hsieh, MD Pathology - Cytopathology Medicare: Not Enrolled in Medicare Practice Location: 150 W Route 66, Glendora, CA 91740 Phone: 626-852-6128 |
Scott Randall Allen, MD Pathology - Blood Banking & Transfusion Medicine Medicare: Accepting Medicare Assignments Practice Location: 250 S Grand Ave, Glendora, CA 91741 Phone: 805-250-9233 |
News Archive
Magellan Health Services Inc. today reported financial results for the second quarter of 2011, as summarized below. For the quarter ended June 30, 2011, the company reported net revenue of $698.3 million, segment profit of $75.9 million, and net income of $34.2 million or $1.07 per diluted common share.
The timing of surgical procedures—afternoon versus morning or Friday versus Monday—doesn't affect the risk of death after surgery, concludes a study in the December issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society.
The U.S. Food and Drug Administration today approved Ingrezza (valbenazine) capsules to treat adults with tardive dyskinesia. This is the first drug approved by the FDA for this condition.
Medtronic, Inc. today announced that the U.S. Food and Drug Administration's (FDA) Circulatory Systems Devices advisory panel voted against the Medtronic Phased RF Ablation System, the first atrial fibrillation ablation therapy under investigation for the treatment of persistent and long-standing persistent atrial fibrillation.
Carnosine and its precursor beta-alanine increases muscle strength, and have recently become extremely popular as dietary supplements in competitive sports.
› Verified 7 days ago